This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| OXSRAD | |
|---|---|
| Name | OXSRAD |
| Organism | Homo sapiens |
| Function | Serine/threonine kinase; regulator of ion transport and stress response |
OXSRAD is a serine/threonine kinase implicated in regulation of ion transport, cell volume, and stress-responsive signaling. It interacts with multiple kinases, transporters, and scaffolds to modulate cellular responses to osmotic, oxidative, and metabolic challenges. Studies across model organisms link it to developmental processes, neuronal excitability, renal function, and cancer-related pathways.
OXSRAD was first characterized through biochemical screens alongside kinases such as WNK1, STK39, AMPK, MAPK14, and AKT1 and later localized to complexes with ion transporters like SLC12A2 and SLC12A1. Genetic and proteomic studies have associated OXSRAD activity with signaling nodes involving SPAK, OSR1, NFATC1, CREB1, and scaffolding proteins including MO25alpha and MO25beta. Functional links to physiological systems have been explored in models used by researchers such as Robert Lefkowitz and labs following paradigms from Edmond Fischer and Albert Claude.
The OXSRAD protein contains a canonical kinase domain related to those in STE20-family kinases, showing conserved motifs observed in structures solved for proteins like PDB entries of MST1 and TAO1. Regulatory regions include phosphorylation sites targeted by upstream kinases such as LKB1 and ATM, motifs for interaction with 14-3-3 proteins seen in studies of FKBP12-associated kinases, and docking sequences analogous to those described for RAF1 and MEK1. Biochemical assays report ATP-binding residues similar to CSNK1A1 and catalytic loops comparable to CAMK2A. Post-translational modifications include phosphorylation by CK2, ubiquitination pathways involving MDM2-like ligases, and SUMOylation patterns reminiscent of TP53 regulation.
At the cellular level, OXSRAD coordinates with ion transport proteins such as NKCC1, KCC2, and NHE1 to influence ionic gradients and cell volume regulation in cells studied in paradigms used by Peter Agre and Gunnar K.]. It functions within osmosensing cascades alongside WNK4, SPAK, and Wnk1-related modules to modulate responses to hypertonic stress analogous to pathways characterized for HOG1 in yeast and p38 MAPK in mammals. OXSRAD activity affects neuronal excitability intersecting with signaling networks including GABA_A receptor modulation studied by researchers following work of Erwin Neher and Bert Sakmann, and it shapes epithelial transport in tissues researched by investigators in renal physiology like Félix Montoya. Crosstalk with metabolic regulators—mTOR, AMPK, and SIRT1—links OXSRAD to nutrient-sensing and autophagy pathways explored in studies by David Sabatini and Roger Tsien. Interaction partners annotated in large-scale proteomics include scaffolds such as PACSIN2, adaptors like GRB2, and membrane components such as Caveolin-1.
Dysregulation of OXSRAD has been implicated in pathologies including salt-sensitive hypertension investigated in cohorts analyzed by teams led by Nicholas Wald and Sir Magdi Yacoub, ischemic injury studied by groups linked to Eric Lazartigues, and tumor progression in malignancies profiled by consortia like The Cancer Genome Atlas and International Cancer Genome Consortium. Mutations or altered expression correlate with phenotypes seen in hereditary tubulopathies researched alongside FHH-associated studies and in neurological disorders investigated by clinicians connected to Evanston Hospital-style clinical neuroscience programs. Therapeutic interest parallels efforts targeting kinases such as ABL1, EGFR, and BRAF; small molecules that modulate OXSRAD activity are being explored in preclinical studies akin to drug discovery pipelines at Novartis, Roche, and Pfizer. Biomarker studies reference cohorts from Framingham Heart Study, UK Biobank, and disease registries curated by World Health Organization collaborators.
Characterization of OXSRAD employs genetic tools such as CRISPR/Cas9 approaches popularized by Jennifer Doudna and Emmanuelle Charpentier, RNAi libraries like those from Broad Institute, and transgenic models generated in facilities associated with The Jackson Laboratory and EMBL. Biochemical methods include kinase assays standardized in protocols developed by labs like C. S. Craik and use mass spectrometry platforms from vendors used by groups such as Mann Lab and Aebersold. Structural investigation uses X-ray crystallography and cryo-EM techniques advanced by groups such as Richard Henderson and Yoshinori Ohsumi-linked methods for autophagy studies. Imaging of OXSRAD dynamics exploits confocal and super-resolution systems utilized in research by Eric Betzig and Stefan Hell, while electrophysiological studies employ patch-clamp setups refined by B. Sakmann-derived training routes. Public databases like UniProt, GeneCards, ENSEMBL, and consortia resources including GTEx and dbGaP host datasets used in OXSRAD research.
Comparative genomics places OXSRAD-related kinases across eukaryotes, with homologs identified in yeast models studied by Paul Nurse and Leland Hartwell, in Drosophila systems advanced by Ed Lewis-inspired genetics, and in zebrafish work from groups like George Streisinger. Phylogenetic analyses reference sequences cataloged by NCBI and alignments informed by methods from Temple F. Smith and Michael Waterman. Functional conservation is observed in osmoregulation modules paralleling pathways in Saccharomyces cerevisiae (high-osmolarity glycerol pathway), invertebrate ion regulation characterized in Caenorhabditis elegans research by Sydney Brenner, and in vertebrate renal adaptations examined in studies of Anura and Teleostei species. Evolutionary pressures shaping OXSRAD domains mirror those described for kinase families in broad surveys by Sean Eddy and Eugene Koonin.